1. Home
  2. PTGX vs MYRG Comparison

PTGX vs MYRG Comparison

Compare PTGX & MYRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • MYRG
  • Stock Information
  • Founded
  • PTGX 2006
  • MYRG 1891
  • Country
  • PTGX United States
  • MYRG United States
  • Employees
  • PTGX N/A
  • MYRG N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • MYRG Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • PTGX Health Care
  • MYRG Industrials
  • Exchange
  • PTGX Nasdaq
  • MYRG Nasdaq
  • Market Cap
  • PTGX 2.9B
  • MYRG 2.5B
  • IPO Year
  • PTGX 2016
  • MYRG N/A
  • Fundamental
  • Price
  • PTGX $51.39
  • MYRG $180.64
  • Analyst Decision
  • PTGX Strong Buy
  • MYRG Buy
  • Analyst Count
  • PTGX 9
  • MYRG 5
  • Target Price
  • PTGX $67.11
  • MYRG $157.00
  • AVG Volume (30 Days)
  • PTGX 1.0M
  • MYRG 193.5K
  • Earning Date
  • PTGX 08-05-2025
  • MYRG 07-30-2025
  • Dividend Yield
  • PTGX N/A
  • MYRG N/A
  • EPS Growth
  • PTGX N/A
  • MYRG N/A
  • EPS
  • PTGX 0.86
  • MYRG 2.12
  • Revenue
  • PTGX $207,801,000.00
  • MYRG $3,380,348,000.00
  • Revenue This Year
  • PTGX N/A
  • MYRG $6.56
  • Revenue Next Year
  • PTGX $47.15
  • MYRG $6.14
  • P/E Ratio
  • PTGX $64.57
  • MYRG $86.02
  • Revenue Growth
  • PTGX N/A
  • MYRG N/A
  • 52 Week Low
  • PTGX $32.50
  • MYRG $86.60
  • 52 Week High
  • PTGX $60.60
  • MYRG $188.71
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 61.93
  • MYRG 77.42
  • Support Level
  • PTGX $52.16
  • MYRG $165.00
  • Resistance Level
  • PTGX $57.24
  • MYRG $184.37
  • Average True Range (ATR)
  • PTGX 1.71
  • MYRG 5.62
  • MACD
  • PTGX -0.25
  • MYRG 0.80
  • Stochastic Oscillator
  • PTGX 55.96
  • MYRG 78.60

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About MYRG MYR Group Inc.

MYR Group Inc is a U.S.-based holding company that provides specialty electrical construction services through its subsidiaries. The company operates through two segments. The transmission and distribution segment provides designing, engineering, procurement, construction, upgrade, maintenance, and repair services on transmission and distribution networks and substation facilities. The commercial and industrial segment provides services such as the design, installation, maintenance, and repair of commercial and industrial wiring, installation of traffic networks, and the installation of bridges. MYR Group generates the majority of its sales from the United States and Canada.

Share on Social Networks: